Home / Deployments

Where ZoyeMed is deployed, by country and status

Deployment, legacy fleet, entity presence and regulatory status are different things. This page keeps them apart.

Más Salud launch with Grupo Salinas, Mexico
CountryStatusDetailRegulatory
MexicoActive ZoyeMed 3.0 deployment44 units delivered under the Más Salud programme with Grupo Salinas as in-country distributor, across Elektra retail locations from Mexico City; multi-phase contract of up to 300 units. 18,224 documented consultations, March 2025 – February 2026.NYCE certified; COFEPRIS in process
ColombiaActive ZoyeMed 3.0 deploymentMulti-year institutional agreement with annual deployments over a three-year term. First unit delivered to Bogotá, Q1 2026.INVIMA in process
IndiaLegacy fleet; software licensed; Virtual Clinics live632+ legacy terminals deployed across public-health programmes since 2010 under the Glocal Healthcare lineage, 8 million+ patient episodes. Zoyel Virtual Clinics live for registered practitioners. ZoyeMed 3.0 contracts in negotiation.Zoyel.Health licensed as Class B Software as a Medical Device under India's CDSCO framework
United Arab Emirates and GCCHeadquarters; no deployment yetZoya Technologies LLC, Dubai. ZoyeMed 3.0 unveiled at WHX Dubai 2026. Built to comply with UAE PDPL with in-country data residency. Enquiries from GCC hospital groups and health authorities go through the enterprise briefing route.Follows each market's medical-device and health-data rules
Malaysia and ASEANEntity established; no deployment yetZoya Technologies Malaysia Sdn Bhd, Kuala Lumpur. MDEC IP registration underway. Zoyel SSM registered under the Malaysian entity. In-country data-residency-compliant architecture confirmed.Malaysia MDA pathway under evaluation
Kazakhstan, Philippines, South Africa, Central Europe, Türkiye and Azerbaijan, VenezuelaDistributor discussionsTerritory discussions at various stages. Nothing on this row is a deployment.Confirmed market by market
ZoyeMed 1.0 in a clinic

Latin America

Retail-anchored primary care at scale in Mexico, institutional deployment in Colombia, Spanish-language operation, NYCE certification and COFEPRIS and INVIMA pathways under way. The reference region for ZoyeMed 3.0.

ZoyeMed 3.0 launch at WHX Dubai

UAE and GCC

Headquarters, regulatory and data-residency readiness, and the WHX Dubai 2026 launch. Hospital groups, health authorities and payers in the Gulf can evaluate the terminal through a Dubai briefing and a demonstration set.

ZoyeMed 3.0 edge AI clinic

Malaysia and ASEAN

A second operating company, IP registered with MDEC, Zoyel SSM delivered from Kuala Lumpur, and a Malaysia MDA regulatory pathway under evaluation. The base for ASEAN programmes.

Programmes start at 25 units.

Three demonstration sets are available. The deployments we serve best run 100+ units across a network.

Request a briefingDistribute in your territory
Zoyel® and ZoyeMed® are registered trademarks of Zoya Technologies LLC (India, China, UAE). The ZoyeMed terminal is general-purpose clinical IT infrastructure, device-agnostic by design, deployed with separately certified medical device and IVD modules supplied under each manufacturer's own conformity marking. Terminal hardware: CE Electrical and NYCE Mexico certified; integrated-configuration CE-MDR assessment, COFEPRIS (Mexico) and INVIMA (Colombia) in process. Zoyel.Health is licensed as Class B Software as a Medical Device under India's CDSCO framework. Zoyel.Health provides clinical decision support; final diagnostic and prescribing decisions remain with a licensed clinician. Regulatory status varies by jurisdiction. Zoyel SSM is delivered jointly by Zoya Technologies LLC and Zoya Technologies Malaysia Sdn Bhd. Longitudinal multimodal model architecture: PCT application filed Q1 2026. Nothing on this site is an offer; commercial terms are set only in a signed agreement.